SYSTEMIC lupus erythematosus doubles mortality risk and drives severe organ complications despite declining overall incidence. While racial and ethnic inequalities in the epidemiology of systemic lupus erythematosus have been documented in clinical settings, comprehensive population-level evidence examining contemporary survival and multisystem morbidity has remained limited. To address this knowledge gap, investigators conducted a large nationwide cohort analysis utilizing primary care records from the Clinical Practice Research Datalink between 2012 and 2023.
The investigation evaluated 4,937 adults aged 18 years and older with newly diagnosed systemic lupus erythematosus alongside 19,707 control individuals matched in a four-to-one ratio by age, sex, and primary care practice. Female patients represented 87.9% of the incident cohort, and the median age at diagnosis was 47.0 years. Prior to diagnosis, common baseline comorbidities included hypertension at 22.6%, stage three or higher chronic kidney disease at 8.8%, diabetes mellitus at 7.8%, and ischemic heart disease at 5.8%. Across the 12-year study window, overall disease incidence declined across all ethnic groups. However, new diagnoses remained highest among individuals from Black ethnic backgrounds, peaking among Black Caribbean adults at 11.07 per 100,000 person-years in 2023.
Flexible parametric and competing-risk modeling demonstrated that patients with systemic lupus erythematosus experienced more than double the risk of all-cause mortality compared with matched controls, yielding a hazard ratio of 2.06 with a 95% confidence interval of 1.84 to 2.32. Beyond reduced survival, affected individuals faced significantly elevated risks for every evaluated complication except solid malignancies. Furthermore, outcomes varied starkly across racial and ethnic groups. Compared with White patients diagnosed with systemic lupus erythematosus, Black patients carried a 64% higher risk of death, represented by a hazard ratio of 1.64 with a 95% confidence interval of 1.05 to 2.55. Black patients also exhibited heightened vulnerability to severe complications, including diabetes, thrombosis, myocarditis or pericarditis, and interstitial lung disease. These findings indicate that declining diagnostic rates have not mitigated the substantial survival deficit associated with systemic lupus erythematosus, underscoring the clinical need for proactive cardiovascular, metabolic, and pulmonary surveillance among high-risk patient populations.
Reference
Patel S et al. The incidence, mortality and complications of systemic lupus erythematosus: a population-level cohort study from 2012 to 2023. Rheumatology (Oxford). 2026;65(5):keag206.
velimir on adobe stock
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
